4//SEC Filing
NOUGUES MAXIMO F 4
Accession 0001437749-26-000921
CIK 0001401667other
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 8:14 PM ET
Size
6.0 KB
Accession
0001437749-26-000921
Insider Transaction Report
Form 4
NOUGUES MAXIMO F
Chief Financial Officer
Transactions
- Sale
Common Stock
2026-01-06$5.84/sh−4,540$26,532→ 199,689 total - Sale
Common Stock
2026-01-07$5.88/sh−6,405$37,655→ 193,284 total
Footnotes (1)
- [F1]Adoption date of referenced 10b5-1(c) plan is: 12-14-2020
Documents
Issuer
PUMA BIOTECHNOLOGY, INC.
CIK 0001401667
Entity typeother
Related Parties
1- filerCIK 0001758507
Filing Metadata
- Form type
- 4
- Filed
- Jan 7, 7:00 PM ET
- Accepted
- Jan 8, 8:14 PM ET
- Size
- 6.0 KB